Sectors & Industries HealthcareHealth Information Services
Best Health Information Service Stocks to Buy Now (2026)
Top health information service stocks in 2026 ranked by overall Zen Rating. "A" Rated stocks have returned an average of +28.50% per year, and are the best health information service stocks to buy now. Learn More.

Industry: Health Information Servic...

Overview Zen Rating Price Value Growth Financials Momentum Sentiment Forecast Dividends Due Diligence

Health Information Services is Zen Rated B and is the 31st ranked industry out of 145 stock market industries

Ticker	Company	DD Score	Valuation Score	Financials Score	Forecast Score	Performance Score	Dividends Score
OMCL	OMNICELL INC	60	71	86	44	40	–
BTSG	BRIGHTSPRING HEALTH SERVICES INC	44	14	57	33	70	–
PGNY	PROGYNY INC	58	43	71	67	50	–
OPRX	OPTIMIZERX CORP	48	57	71	44	20	–
GDRX	GOODRX HOLDINGS INC	39	29	43	56	30	–

Upgrade to Premium to View More

Use Due Diligence Score to quickly analyze stock fundamentals, even if you don't have a finance background. We run time-tested due diligence checks inspired by legendary investors like Warren Buffett, and score each company based on how many they pass/fail.

Already have access to Premium?

Health Information Service Stocks FAQ

What are the best health information service stocks to buy right now in Sep 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best health information service stocks to buy right now are:

1. Omnicell (NASDAQ:OMCL)

Omnicell (NASDAQ:OMCL) is the #1 top health information service stock out of 50 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Omnicell (NASDAQ:OMCL) is: Value: B, Growth: B, Momentum: C, Sentiment: B, Safety: B, Financials: C, and AI: C.

Omnicell (NASDAQ:OMCL) has a Due Diligence Score of 60, which is 28 points higher than the health information service industry average of 32.

OMCL passed 19 out of 33 due diligence checks and has strong fundamentals. Omnicell has seen its stock return 3.87% over the past year, overperforming other health information service stocks by 41 percentage points.

Omnicell has an average 1 year price target of $53.33, an upside of 59.16% from Omnicell's current stock price of $33.51.

Omnicell stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Omnicell, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Brightspring Health Services (NASDAQ:BTSG)

Brightspring Health Services (NASDAQ:BTSG) is the #2 top health information service stock out of 50 with a Zen Rating of B. Stocks with a rating of B have had an average return of +17.17% per year. Learn more.

The Component Grade breakdown for Brightspring Health Services (NASDAQ:BTSG) is: Value: C, Growth: A, Momentum: B, Sentiment: B, Safety: B, Financials: C, and AI: C.

Brightspring Health Services (NASDAQ:BTSG) has a Due Diligence Score of 44, which is 12 points higher than the health information service industry average of 32.

BTSG passed 15 out of 33 due diligence checks and has strong fundamentals. Brightspring Health Services has seen its stock return 121.85% over the past year, overperforming other health information service stocks by 159 percentage points.

Brightspring Health Services has an average 1 year price target of $76.00, an upside of 26.04% from Brightspring Health Services's current stock price of $60.30.

Brightspring Health Services stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 13 analysts covering Brightspring Health Services, 76.92% have issued a Strong Buy rating, 23.08% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Progyny (NASDAQ:PGNY)

Progyny (NASDAQ:PGNY) is the #3 top health information service stock out of 50 with a Zen Rating of B. Stocks with a rating of B have had an average return of +17.17% per year. Learn more.

The Component Grade breakdown for Progyny (NASDAQ:PGNY) is: Value: C, Growth: B, Momentum: C, Sentiment: C, Safety: B, Financials: A, and AI: C.

Progyny (NASDAQ:PGNY) has a Due Diligence Score of 58, which is 26 points higher than the health information service industry average of 32.

PGNY passed 19 out of 33 due diligence checks and has strong fundamentals. Progyny has seen its stock return 25.85% over the past year, overperforming other health information service stocks by 63 percentage points.

Progyny has an average 1 year price target of $33.50, an upside of 20.29% from Progyny's current stock price of $27.85.

Progyny stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 10 analysts covering Progyny, 70% have issued a Strong Buy rating, 10% have issued a Buy, 20% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the health information service stocks with highest dividends?

Out of 4 health information service stocks that have issued dividends in the past year, the 3 health information service stocks with the highest dividend yields are:

1. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 11.47%, which is 8 percentage points higher than the health information service industry average of 3.71%. Spok Holdings's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 207.9% indicates that its high dividend yield might not be sustainable for the long-term.

2. Nrc Health (NASDAQ:NRC)

Nrc Health (NASDAQ:NRC) has an annual dividend yield of 2.69%, which is -1 percentage points lower than the health information service industry average of 3.71%. Nrc Health's dividend payout is not stable, having dropped more than 10% four times in the last 10 years. Nrc Health's dividend has not shown consistent growth over the last 10 years.

Nrc Health's dividend payout ratio of 250% indicates that its dividend yield might not be sustainable for the long-term.

3. Healthstream (NASDAQ:HSTM)

Healthstream (NASDAQ:HSTM) has an annual dividend yield of 0.46%, which is -3 percentage points lower than the health information service industry average of 3.71%. Healthstream's dividend payout is not stable, having dropped more than 10% one times in the last 10 years. Healthstream's dividend has not shown consistent growth over the last 10 years.

Healthstream's dividend payout ratio of 18.3% indicates that its dividend yield is sustainable for the long-term.

Why are health information service stocks up?

Health information service stocks were up 3.5% in the last day, and up 2.62% over the last week.

We couldn't find a catalyst for why health information service stocks are up.

What are the most undervalued health information service stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued health information service stocks right now are:

1. Nutex Health (NASDAQ:NUTX)

Nutex Health (NASDAQ:NUTX) is the most undervalued health information service stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Nutex Health has a valuation score of 43, which is 25 points higher than the health information service industry average of 18. It passed 3 out of 7 valuation due diligence checks.

Nutex Health's stock has gained 126.87% in the past year. It has overperformed other stocks in the health information service industry by 164 percentage points.

2. Ge Healthcare Technologies (NASDAQ:GEHC)

Ge Healthcare Technologies (NASDAQ:GEHC) is the second most undervalued health information service stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ge Healthcare Technologies has a valuation score of 57, which is 39 points higher than the health information service industry average of 18. It passed 4 out of 7 valuation due diligence checks.

Ge Healthcare Technologies's stock has dropped -17.37% in the past year. It has overperformed other stocks in the health information service industry by 20 percentage points.

3. Optimizerx (NASDAQ:OPRX)

Optimizerx (NASDAQ:OPRX) is the third most undervalued health information service stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Optimizerx has a valuation score of 57, which is 39 points higher than the health information service industry average of 18. It passed 4 out of 7 valuation due diligence checks.

Optimizerx's stock has dropped -54.93% in the past year. It has underperformed other stocks in the health information service industry by -18 percentage points.

Are health information service stocks a good buy now?

48.72% of health information service stocks rated by analysts are a strong buy right now. On average, analysts expect health information service stocks to rise by 13.61% over the next year.

2.5% of health information service stocks have a Zen Rating of A (Strong Buy), 25% of health information service stocks are rated B (Buy), 65% are rated C (Hold), 7.5% are rated D (Sell), and 0% are rated F (Strong Sell).

What is the average p/e ratio of the health information services industry?

The average P/E ratio of the health information services industry is 9.64x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.